hearing_members

Committee members present at hearings.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

55 rows where package_id = "CHRG-107hhrg82439" sorted by name

✎ View and edit SQL

This data as json, CSV (advanced)

role 1

Link package_id name ▼ role bioguide_id
CHRG-107hhrg82439,Albert Russell Wynn EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Albert Russell Wynn committee member W000784
CHRG-107hhrg82439,Anna G. Eshoo EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Anna G. Eshoo committee member E000215
CHRG-107hhrg82439,Barbara Cubin EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Barbara Cubin committee member C000962
CHRG-107hhrg82439,Bart Gordon EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Bart Gordon committee member  
CHRG-107hhrg82439,Bart Stupak EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Bart Stupak committee member S001045
CHRG-107hhrg82439,Bill Luther EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Bill Luther committee member  
CHRG-107hhrg82439,Bobby L. Rush EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Bobby L. Rush committee member R000515
CHRG-107hhrg82439,Charles F. Bass EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Charles F. Bass committee member B000220
CHRG-107hhrg82439,Charles W. Norwood EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Charles W. Norwood committee member N000159
CHRG-107hhrg82439,Christopher Cox EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Christopher Cox committee member  
CHRG-107hhrg82439,Christopher John EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Christopher John committee member J000110
CHRG-107hhrg82439,Cliff Stearns EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Cliff Stearns committee member S000822
CHRG-107hhrg82439,Diana DeGette EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Diana DeGette committee member D000197
CHRG-107hhrg82439,Ed Bryant EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Ed Bryant committee member B000996
CHRG-107hhrg82439,Ed Whitfield EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Ed Whitfield committee member W000413
CHRG-107hhrg82439,Edolphus Towns EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Edolphus Towns committee member T000326
CHRG-107hhrg82439,Edward J. Markey EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Edward J. Markey committee member M000133
CHRG-107hhrg82439,Eliot L. Engel EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Eliot L. Engel committee member E000179
CHRG-107hhrg82439,Ernie Fletcher EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Ernie Fletcher committee member  
CHRG-107hhrg82439,Frank Pallone, Jr. EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Frank Pallone, Jr. committee member P000034
CHRG-107hhrg82439,Fred Upton EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Fred Upton committee member U000031
CHRG-107hhrg82439,Gene Green EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Gene Green committee member G000410
CHRG-107hhrg82439,George Radanovich EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 George Radanovich committee member R000004
CHRG-107hhrg82439,Greg Ganske EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Greg Ganske committee member G000041
CHRG-107hhrg82439,Greg Walden EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Greg Walden committee member W000791
CHRG-107hhrg82439,Heather Wilson EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Heather Wilson committee member W000789
CHRG-107hhrg82439,Henry A. Waxman EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Henry A. Waxman committee member W000215
CHRG-107hhrg82439,James C. Greenwood EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 James C. Greenwood committee member G000439
CHRG-107hhrg82439,Jane Harman EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Jane Harman committee member H000213
CHRG-107hhrg82439,Joe Barton EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Joe Barton committee member B000213
CHRG-107hhrg82439,John B. Shadegg EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 John B. Shadegg committee member S000275
CHRG-107hhrg82439,John D. Dingell EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 John D. Dingell committee member D000355
CHRG-107hhrg82439,John Shimkus EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 John Shimkus committee member S000364
CHRG-107hhrg82439,Joseph R. Pitts EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Joseph R. Pitts committee member P000373
CHRG-107hhrg82439,Karen McCarthy EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Karen McCarthy committee member M000316
CHRG-107hhrg82439,Lee Terry EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Lee Terry committee member T000459
CHRG-107hhrg82439,Lois Capps EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Lois Capps committee member C001036
CHRG-107hhrg82439,Mary Bono Mack EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Mary Bono Mack committee member B001228
CHRG-107hhrg82439,Michael Bilirakis EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Michael Bilirakis committee member B000463
CHRG-107hhrg82439,Michael F. Doyle EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Michael F. Doyle committee member D000482
CHRG-107hhrg82439,Nathan Deal EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Nathan Deal committee member D000168
CHRG-107hhrg82439,Paul E. Gillmor EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Paul E. Gillmor committee member G000210
CHRG-107hhrg82439,Peter Deutsch EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Peter Deutsch committee member D000275
CHRG-107hhrg82439,Ralph M. Hall EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Ralph M. Hall committee member H000067
CHRG-107hhrg82439,Richard Burr EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Richard Burr committee member B001135
CHRG-107hhrg82439,Rick Boucher EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Rick Boucher committee member  
CHRG-107hhrg82439,Robert L. Ehrlich Jr. EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Robert L. Ehrlich Jr. committee member  
CHRG-107hhrg82439,Roy Blunt EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Roy Blunt committee member B000575
CHRG-107hhrg82439,Sherrod Brown EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Sherrod Brown committee member B000944
CHRG-107hhrg82439,Steve Buyer EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Steve Buyer committee member  
CHRG-107hhrg82439,Ted Strickland EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Ted Strickland committee member S001004
CHRG-107hhrg82439,Thomas M. Barrett EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Thomas M. Barrett committee member B000177
CHRG-107hhrg82439,Tom Davis EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Tom Davis committee member  
CHRG-107hhrg82439,Tom Sawyer EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Tom Sawyer committee member  
CHRG-107hhrg82439,Vito Fossella EXAMINING ISSUES RELATED TO COMPETITION IN THE PHARMACEUTICAL MARKETPLACE: A REVIEW OF THE FTC REPORT, GENERIC DRUG ENTRY PRIOR TO PATENT EXPIRATION CHRG-107hhrg82439 Vito Fossella committee member F000440

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE hearing_members (
    package_id TEXT NOT NULL REFERENCES hearings(package_id),
    name TEXT NOT NULL,
    role TEXT,
    bioguide_id TEXT,
    PRIMARY KEY (package_id, name)
);
CREATE INDEX idx_hm_name ON hearing_members(name);
CREATE INDEX idx_hm_bioguide ON hearing_members(bioguide_id);
CREATE INDEX idx_hearing_members_package ON hearing_members(package_id);